Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01711294 · ClinicalTrials.gov registry record · NA
Evaluation of PCLs Using Three EUS-FNA Needles
A NA study of Pancreatic Cystic Lesions, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- NA
- Development phase
- 250
- Enrollment target
- 8
- Study locations
NCT01711294 is a NA study of Pancreatic Cystic Lesions that has completed, run by Boston Scientific Corporation. The registered enrollment target is 250 participants. The trial reports 8 study locations across 6 states.
The verdict
NCT01711294, a NA study of Pancreatic Cystic Lesions, has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 250 participants
- Enrollment target
- 8
- Study locations
Study Summary
To document impact of EUS-FNA needle size and flexibility on effectiveness of pancreatic cystic lesions (PCL) aspiration, on ability to obtain sufficient material for standard diagnostic testing, and on diagnostic accuracy of EUS-FNA aspirate for differentiation of mucinous (pre-malignant) and non-mucinous cysts.
Conditions Studied
Interventions
- DEVICE 19 G Flex Needle
- DEVICE 22 G Needle
- DEVICE 19 G Needle
Study Locations (8)
Massachusetts
- Massachusetts General Hospital - Boston
- Beth Israel Deaconess Medical Center - Boston
Other
- Changhai Hospital - Shanghai
- Asian Institute of Gastroenterology - Hyderabad
Arizona
- Mayo Clinic - Scottsdale
Florida
- Mayo Clinic - Jacksonville
Indiana
- Indiana University Medical Center - Indianapolis
New York
- New York Presbyterian Hospital/Columbia University Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2013-01-08 |
| Est. Completion | 2019-12-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01711294
The ClinicalTrials.gov registry entry for NCT01711294 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pancreatic Cystic Lesions appearing as the primary indexed condition, and to 3 interventions - of which 19 G Flex Needle is the first listed.
NCT01711294 reports 8 study locations spanning 6 distinct geographic areas - top geographies include Massachusetts, Other, Arizona.
Frequently Asked Questions
What is clinical trial NCT01711294 about?
NCT01711294 is a clinical study titled "Evaluation of PCLs Using Three EUS-FNA Needles". To document impact of EUS-FNA needle size and flexibility on effectiveness of pancreatic cystic lesions (PCL) aspiration, on ability to obtain sufficient material for standard diagnostic testing, and on diagnostic accuracy of EUS-FNA aspirate for differentiation of mucinous (pre-malignant) and non-m...
What is the current status of trial NCT01711294?
This trial is currently completed. It is a NA study. The enrollment target is 250 participants. The study started on 2013-01-08. Estimated completion is 2019-12-18.
What conditions does trial NCT01711294 study?
This clinical trial studies the following conditions: Pancreatic Cystic Lesions.
What interventions are being tested in trial NCT01711294?
The interventions under investigation include: 19 G Flex Needle (DEVICE), 22 G Needle (DEVICE), 19 G Needle (DEVICE).
Who is sponsoring clinical trial NCT01711294?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01711294 being conducted?
This trial has 8 study locations across Arizona, Florida, Indiana, Massachusetts, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pancreatic Cystic Lesions
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.